159 related articles for article (PubMed ID: 22406446)
21. Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide.
Yan SD; Roher A; Chaney M; Zlokovic B; Schmidt AM; Stern D
Biochim Biophys Acta; 2000 Jul; 1502(1):145-57. PubMed ID: 10899440
[TBL] [Abstract][Full Text] [Related]
22. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.
Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
Med Hypotheses; 2005; 64(6):1205-7. PubMed ID: 15823718
[TBL] [Abstract][Full Text] [Related]
23. Site-specific glycation of Aβ1-42 affects fibril formation and is neurotoxic.
Ng J; Kaur H; Collier T; Chang K; Brooks AES; Allison JR; Brimble MA; Hickey A; Birch NP
J Biol Chem; 2019 May; 294(22):8806-8818. PubMed ID: 30996005
[TBL] [Abstract][Full Text] [Related]
24. High dietary advanced glycation end products are associated with poorer spatial learning and accelerated Aβ deposition in an Alzheimer mouse model.
Lubitz I; Ricny J; Atrakchi-Baranes D; Shemesh C; Kravitz E; Liraz-Zaltsman S; Maksin-Matveev A; Cooper I; Leibowitz A; Uribarri J; Schmeidler J; Cai W; Kristofikova Z; Ripova D; LeRoith D; Schnaider-Beeri M
Aging Cell; 2016 Apr; 15(2):309-16. PubMed ID: 26781037
[TBL] [Abstract][Full Text] [Related]
25. Glycation exacerbates the neuronal toxicity of β-amyloid.
Li XH; Du LL; Cheng XS; Jiang X; Zhang Y; Lv BL; Liu R; Wang JZ; Zhou XW
Cell Death Dis; 2013 Jun; 4(6):e673. PubMed ID: 23764854
[TBL] [Abstract][Full Text] [Related]
26. Yeast protein glycation in vivo by methylglyoxal. Molecular modification of glycolytic enzymes and heat shock proteins.
Gomes RA; Vicente Miranda H; Silva MS; Graça G; Coelho AV; Ferreira AE; Cordeiro C; Freire AP
FEBS J; 2006 Dec; 273(23):5273-87. PubMed ID: 17064314
[TBL] [Abstract][Full Text] [Related]
27. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD
Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus.
Valente T; Gella A; Fernàndez-Busquets X; Unzeta M; Durany N
Neurobiol Dis; 2010 Jan; 37(1):67-76. PubMed ID: 19778613
[TBL] [Abstract][Full Text] [Related]
29. Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis.
Chen K; Maley J; Yu PH
J Neurochem; 2006 Dec; 99(5):1413-24. PubMed ID: 17074066
[TBL] [Abstract][Full Text] [Related]
30. Aβ-AGE aggravates cognitive deficit in rats via RAGE pathway.
Chen C; Li XH; Tu Y; Sun HT; Liang HQ; Cheng SX; Zhang S
Neuroscience; 2014 Jan; 257():1-10. PubMed ID: 24188791
[TBL] [Abstract][Full Text] [Related]
31. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
32. Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease.
Leclerc E; Sturchler E; Vetter SW; Heizmann CW
Rev Neurosci; 2009; 20(2):95-110. PubMed ID: 19774788
[TBL] [Abstract][Full Text] [Related]
33. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
[TBL] [Abstract][Full Text] [Related]
34. Regulation of in vitro Aβ1-40 aggregation mediated by small molecules.
Kim HY; Kim Y; Han G; Kim DJ
J Alzheimers Dis; 2010; 22(1):73-85. PubMed ID: 20847447
[TBL] [Abstract][Full Text] [Related]
35. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease.
Lonskaya I; Shekoyan AR; Hebron ML; Desforges N; Algarzae NK; Moussa CE
J Alzheimers Dis; 2013; 33(1):231-47. PubMed ID: 22954671
[TBL] [Abstract][Full Text] [Related]
36. Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?
Lemere CA; Oh J; Stanish HA; Peng Y; Pepivani I; Fagan AM; Yamaguchi H; Westmoreland SV; Mansfield KG
Rejuvenation Res; 2008 Apr; 11(2):321-32. PubMed ID: 18341428
[TBL] [Abstract][Full Text] [Related]
37. Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease.
Rahmadi A; Steiner N; Münch G
Clin Chem Lab Med; 2011 Mar; 49(3):385-91. PubMed ID: 21275816
[TBL] [Abstract][Full Text] [Related]
38. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease.
Dei R; Takeda A; Niwa H; Li M; Nakagomi Y; Watanabe M; Inagaki T; Washimi Y; Yasuda Y; Horie K; Miyata T; Sobue G
Acta Neuropathol; 2002 Aug; 104(2):113-22. PubMed ID: 12111353
[TBL] [Abstract][Full Text] [Related]
39. Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease?
Krautwald M; Münch G
Exp Gerontol; 2010 Oct; 45(10):744-51. PubMed ID: 20211718
[TBL] [Abstract][Full Text] [Related]
40. Promotion of amyloid beta protein misfolding and fibrillogenesis by a lipid oxidation product.
Liu L; Komatsu H; Murray IV; Axelsen PH
J Mol Biol; 2008 Apr; 377(4):1236-50. PubMed ID: 18304576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
